279 related articles for article (PubMed ID: 20967271)
1. Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection.
Schmid A; Gianella S; von Wyl V; Metzner KJ; Scherrer AU; Niederöst B; Althaus CF; Rieder P; Grube C; Joos B; Weber R; Fischer M; Günthard HF
PLoS One; 2010 Oct; 5(10):e13310. PubMed ID: 20967271
[TBL] [Abstract][Full Text] [Related]
2. Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome.
Pasternak AO; Jurriaans S; Bakker M; Prins JM; Berkhout B; Lukashov VV
PLoS One; 2009 Dec; 4(12):e8490. PubMed ID: 20046870
[TBL] [Abstract][Full Text] [Related]
3. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
[TBL] [Abstract][Full Text] [Related]
4. Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy.
Fischer M; Joos B; Niederöst B; Kaiser P; Hafner R; von Wyl V; Ackermann M; Weber R; Günthard HF
Retrovirology; 2008 Nov; 5():107. PubMed ID: 19036147
[TBL] [Abstract][Full Text] [Related]
5. Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts.
Fischer M; Wong JK; Russenberger D; Joos B; Opravil M; Hirschel B; Trkola A; Kuster H; Weber R; Günthard HF;
Antivir Ther; 2002 Jun; 7(2):91-103. PubMed ID: 12212929
[TBL] [Abstract][Full Text] [Related]
6. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
[TBL] [Abstract][Full Text] [Related]
7. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the turnover of transcriptional subclasses of HIV-1-infected cells.
Althaus CL; Joos B; Perelson AS; Günthard HF
PLoS Comput Biol; 2014 Oct; 10(10):e1003871. PubMed ID: 25340797
[TBL] [Abstract][Full Text] [Related]
9. Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants.
McManus M; Mick E; Hudson R; Mofenson LM; Sullivan JL; Somasundaran M; Luzuriaga K;
PLoS One; 2016; 11(4):e0154391. PubMed ID: 27104621
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy.
Martínez-Bonet M; Puertas MC; Fortuny C; Ouchi D; Mellado MJ; Rojo P; Noguera-Julian A; Muñoz-Fernández MA; Martinez-Picado J
Clin Infect Dis; 2015 Oct; 61(7):1169-78. PubMed ID: 26063721
[TBL] [Abstract][Full Text] [Related]
11. Comparison of droplet digital PCR and seminested real-time PCR for quantification of cell-associated HIV-1 RNA.
Kiselinova M; Pasternak AO; De Spiegelaere W; Vogelaers D; Berkhout B; Vandekerckhove L
PLoS One; 2014; 9(1):e85999. PubMed ID: 24465831
[TBL] [Abstract][Full Text] [Related]
12. Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy.
Fischer M; Joos B; Wong JK; Ott P; Opravil M; Hirschel B; Weber R; Günthard HF;
J Infect Dis; 2004 Jan; 189(2):273-85. PubMed ID: 14722893
[TBL] [Abstract][Full Text] [Related]
13. Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.
Wyl Vv; Gianella S; Fischer M; Niederoest B; Kuster H; Battegay M; Bernasconi E; Cavassini M; Rauch A; Hirschel B; Vernazza P; Weber R; Joos B; Günthard HF;
PLoS One; 2011; 6(11):e27463. PubMed ID: 22102898
[TBL] [Abstract][Full Text] [Related]
14. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
Ghosn J; Leruez-Ville M; Blanche J; Delobelle A; Beaudoux C; Mascard L; Lecuyer H; Canestri A; Landman R; Zucman D; Ponscarme D; Rami A; Viard JP; Spire B; Rouzioux C; Costagliola D; Suzan-Monti M;
Clin Infect Dis; 2014 Jun; 58(12):1763-70. PubMed ID: 24647014
[TBL] [Abstract][Full Text] [Related]
16. Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia.
Pasternak AO; Jurriaans S; Bakker M; Berkhout B; Lukashov VV
AIDS; 2010 Jul; 24(11):1641-9. PubMed ID: 20543660
[TBL] [Abstract][Full Text] [Related]
17. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Chéret A; Nembot G; Mélard A; Lascoux C; Slama L; Miailhes P; Yeni P; Abel S; Avettand-Fenoel V; Venet A; Chaix ML; Molina JM; Katlama C; Goujard C; Tamalet C; Raffi F; Lafeuillade A; Reynes J; Ravaux I; Hoën B; Delfraissy JF; Meyer L; Rouzioux C;
Lancet Infect Dis; 2015 Apr; 15(4):387-96. PubMed ID: 25701561
[TBL] [Abstract][Full Text] [Related]
18. An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy.
Alagaratnam J; Peters H; Francis K; Kay N; Gilleece Y; Finnerty FP; Grimes RE; Parry S; Portman M; Wait BC; Shah R; Roedling S; Hawkins DA; Chitty S; Sarner L; Marcus R; Hartley A; Nori AV; Rosenvinge M; Taylor GP;
AIDS Res Ther; 2020 Jul; 17(1):41. PubMed ID: 32660502
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
Ghosn J; Pellegrin I; Goujard C; Deveau C; Viard JP; Galimand J; Harzic M; Tamalet C; Meyer L; Rouzioux C; Chaix ML;
AIDS; 2006 Jan; 20(2):159-70. PubMed ID: 16511408
[TBL] [Abstract][Full Text] [Related]
20. Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.
Evering TH; Mehandru S; Racz P; Tenner-Racz K; Poles MA; Figueroa A; Mohri H; Markowitz M
PLoS Pathog; 2012 Feb; 8(2):e1002506. PubMed ID: 22319447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
